Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rory Bennett

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Clinical Lymphoma, Myeloma & Leukemia|June 13, 2024
SOHO State of the Art Updates and Next Questions | Current Evidence and Future Directions for Bispecific Antibodies in Large B-Cell LymphomaRory Bennett, Michael Dickinson
Blood Cancer Journal|February 20, 2024
Update on the management of relapsed/refractory chronic lymphocytic leukemiaRory Bennett, John F Seymour
Clinical Lymphoma, Myeloma & Leukemia|August 15, 2022
SOHO State of the Art Updates and Next Questions | Mechanisms of Resistance to BCL2 Inhibitor Therapy in Chronic Lymphocytic Leukemia and Potential Future Therapeutic DirectionsRory Bennett, Ella Thompson, Constantine Tam
International Journal of Laboratory Hematology|February 15, 2022
Value of cerebrospinal fluid white cell count and protein level in predicting leptomeningeal involvement by systemic aggressive B-cell lymphomaRory Bennett, Anna Ruskova, Michelle Petrasich, et al.
Journal of Hematology & Oncology|July 8, 2023
Unresolved questions in selection of therapies for treatment-naïve chronic lymphocytic leukemiaRory Bennett, Mary Ann Anderson, John F Seymour
IEEE Open Journal of Engineering in Medicine and Biology|December 19, 2024
Surface-Based Ultrasound Scans for the Screening of Prostate CancerRory Bennett, Tristan Barrett, Vincent J Gnanapragasam, et al.
American Journal of Hematology|May 10, 2023
Diffuse large B-cell lymphoma at risk of secondary CNS involvement: The inefficacy of intravenous high-dose methotrexate CNS prophylaxis and the importance of baseline cerebrospinal fluid analysisRory Bennett, Anna Ruskova, Christin Coomarasamy, et al.
Internal Medicine Journal|June 20, 2025
A single-institution study of allograft outcomes for chronic lymphocytic leukaemia over 20 yearsRory Bennett, Thomas Frawley, Philip A Thompson, et al.
Hemasphere|June 9, 2026
Obinutuzumab, lenalidomide, and venetoclax for the initial treatment of patients with advanced-stage follicular lymphoma: Results of the Phase Ib/II LEVERAGE studyChan Y Cheah, Piers Blombery, Amanda Johnston, et al.
Blood Advances|July 28, 2022
Enrichment of BTK Leu528Trp mutations in patients with CLL on zanubrutinib: potential for pirtobrutinib cross-resistancePiers Blombery, Ella R Thompson, Thomas E Lew, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Clinical Lymphoma, Myeloma & Leukemia|June 13, 2024
SOHO State of the Art Updates and Next Questions | Current Evidence and Future Directions for Bispecific Antibodies in Large B-Cell LymphomaRory Bennett, Michael Dickinson
Blood Cancer Journal|February 20, 2024
Update on the management of relapsed/refractory chronic lymphocytic leukemiaRory Bennett, John F Seymour
Clinical Lymphoma, Myeloma & Leukemia|August 15, 2022
SOHO State of the Art Updates and Next Questions | Mechanisms of Resistance to BCL2 Inhibitor Therapy in Chronic Lymphocytic Leukemia and Potential Future Therapeutic DirectionsRory Bennett, Ella Thompson, Constantine Tam
International Journal of Laboratory Hematology|February 15, 2022
Value of cerebrospinal fluid white cell count and protein level in predicting leptomeningeal involvement by systemic aggressive B-cell lymphomaRory Bennett, Anna Ruskova, Michelle Petrasich, et al.
Journal of Hematology & Oncology|July 8, 2023
Unresolved questions in selection of therapies for treatment-naïve chronic lymphocytic leukemiaRory Bennett, Mary Ann Anderson, John F Seymour
IEEE Open Journal of Engineering in Medicine and Biology|December 19, 2024
Surface-Based Ultrasound Scans for the Screening of Prostate CancerRory Bennett, Tristan Barrett, Vincent J Gnanapragasam, et al.
American Journal of Hematology|May 10, 2023
Diffuse large B-cell lymphoma at risk of secondary CNS involvement: The inefficacy of intravenous high-dose methotrexate CNS prophylaxis and the importance of baseline cerebrospinal fluid analysisRory Bennett, Anna Ruskova, Christin Coomarasamy, et al.
Internal Medicine Journal|June 20, 2025
A single-institution study of allograft outcomes for chronic lymphocytic leukaemia over 20 yearsRory Bennett, Thomas Frawley, Philip A Thompson, et al.
Hemasphere|June 9, 2026
Obinutuzumab, lenalidomide, and venetoclax for the initial treatment of patients with advanced-stage follicular lymphoma: Results of the Phase Ib/II LEVERAGE studyChan Y Cheah, Piers Blombery, Amanda Johnston, et al.
Blood Advances|July 28, 2022
Enrichment of BTK Leu528Trp mutations in patients with CLL on zanubrutinib: potential for pirtobrutinib cross-resistancePiers Blombery, Ella R Thompson, Thomas E Lew, et al.
Pageof 2